{
    "Trade/Device Name(s)": [
        "Axis-Shield anti-CCP"
    ],
    "Submitter Information": "Axis-Shield Diagnostics Ltd.",
    "510(k) Number": "K110296",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023285"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHX"
    ],
    "Summary Letter Date": "July 19, 2011",
    "Summary Letter Received Date": "July 21, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5775"
    ],
    "Regulation Name(s)": [
        "Rheumatoid factor immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-cyclic citrullinated peptide (CCP) IgG autoantibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum Separator Tube",
        "EDTA tube",
        "Lithium heparin tube",
        "Sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control",
        "Reference Material"
    ],
    "Document Summary": "FDA 510(k) summary for Axis-Shield anti-CCP ELISA assay for detection of IgG autoantibodies to CCP in serum and plasma to aid in rheumatoid arthritis diagnosis",
    "Indications for Use Summary": "A semi-quantitative/qualitative ELISA for detection of IgG autoantibodies to cyclic citrullinated peptide (CCP) in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis, for use with other clinical and laboratory information.",
    "fda_folder": "Immunology"
}